Dr Lal PathLabs provides update on proposed acquisition of Delta Ria & Pathology
To complete acquisition by 31 March 2017
Dr Lal PathLabs announced that the Company is in the process of completing the due diligence and legal documentation for the acquisition of 100% stake in Delta Ria & Pathology, post which it expects to complete the acquisition by 31 March 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content